Accounting ProFound Therapeutics Receives Investment to Tackle Preeclampsia and EclampsiaBy AdminBitAugust 27, 20260 Up to $35 million from the Gates Foundation will support ProFound’s use of its platform, datasets, and algorithms to identify new drug targets and biomarkers for preeclampsia and eclampsia
